Squamous papillomas of the lung are an uncommon feature of recurrent respiratory papillomatosis, occurring in fewer than 1% of cases. We describe a 23-year-old patient with pulmonary papillomas who developed a fatal squamous cell carcinoma of the lung. PCR-based human papillomavirus (HPV) typing showed the presence of HPV 11 DNA in both benign papillomas and invasive carcinoma. A review of the literature reveals four reports of malignant transformation of juvenile-onset recurrent respiratory papillomatosis in which HPV typing was performed. Similar clinical features are noted in all of the reports; specifically, each case has arisen in a young adult man with a history of papillomatosis since childhood. In each of the cases, HPV 11 was identified in association with the squamous cell carcinoma. Although HPV 11 is uncommonly associated with the development of invasive carcinoma at other sites, these findings suggest that it is correlated with malignant transformation in the setting of juvenile-onset recurrent respiratory papillomatosis.
Juvenile-onset recurrent respiratory papillomatosis (RRP) is characterized by numerous squamous papillomas of the respiratory tract secondary to infection with human papillomavirus (HPV) types 6 and 11 (1, 2) . HPV is thought to be acquired at the time of vaginal delivery in the presence of genital lesions, and patients typically present with symptoms of hoarseness or respiratory obstruction in childhood or adolescence. In the majority of cases, the papillomas are confined to the larynx; only 5% of patients exhibit more distal involvement of the trachea, and involvement of lung parenchyma occurs in fewer than 1% of cases (1, 2) .
Pulmonary involvement by RRP is twice as frequent in males than in females and is associated with an aggressive clinical course. Most patients require numerous excisions, frequently require tracheostomy, and ultimately die as a result of respiratory insufficiency or infections (2) . Malignant transformation of laryngeal or pulmonary lesions is a very rare event in the absence of prior irradiation; fewer than 20 cases are reported in the English literature (3) (4) (5) (6) . It remains unclear whether the risk of malignant transformation is dependent on the HPV serotype involved.
We describe a patient with pulmonary involvement by RRP who developed a squamous cell carcinoma of the lung. Polymerase chain reaction (PCR) typing performed at postmortem examination showed the presence of HPV 11 DNA in both the papillomas and squamous cell carcinoma. This is the fifth report of an association between HPV 11 and malignant transformation of pulmonary papillomas (3, 4, 6, 7) . Together, these five cases suggest a stereotypical clinical setting for the emergence of invasive carcinoma from RRP.
CASE REPORT
The patient was a 23-year-old white man with a history of RRP, initially diagnosed at age 5. By age 10, he had developed laryngeal, tracheal, and pulmonary papillomas. He underwent more than 100 surgical excisions and laser ablations, required multiple tracheotomies for tracheal obstruction, and was frequently treated for postobstructive pneumonia and pulmonary abscesses. He was also treated with interferon-␣, acyclovir, indol-3-carbanol, and an adjunctive trial of measles vaccine injection. Clinical response was noted only to therapy with interferon-␣, which reduced the bulk of his papillomas and the frequency of required surgical interventions. During late adolescence and into young adulthood, the patient smoked approximately one half to one pack of cigarettes per day (Ͻ10 pack-year history total).
At age 22, the patient began to complain of weight loss and thoracic pain radiating to the scapula. Chest radiographs demonstrated an enlarging right upper lobe mass, and a bronchial washing showed invasive squamous cell carcinoma. He was treated with radiotherapy for control of pain and local control of the tumor. Subsequent chest radiographs demonstrated continuing enlargement of the mass, which seemed to compress the right main bronchus. He experienced progressive respiratory compromise and died approximately 1 year after the diagnosis of carcinoma.
MATERIALS AND METHODS

DNA Extraction
Five, 10-sections of formalin-fixed, paraffinembedded tissue obtained at autopsy were deparaffinized using xylene and ethanol washes and were digested overnight at 65°C in digestion buffer (Tris pH 7.5, 20 mM EDTA, 1% SDS) containing 200 g/L proteinase K. Samples were boiled with Chelex 100 resin for 20 min and centrifuged, the aqueous phase was transferred to a new tube, and DNA was quantitated by spectrophotometry.
PCR Amplification
PCR analysis was carried out using the GeneAmp kit (Perkin-Elmer, Foster City, CA) with HPV consensus primers as described by Manos et al. (8) : MY09-CGTCCMARRGGAWACTGATC; MY11-GCM-CAGGGWCATAAYAATGG where R ϭ AϩG, W ϭ AϩT, M ϭ AϩC, and Y ϭ CϩT. As a control for intact amplifiable DNA, primers for the ␤-globin gene were also used in the same reaction: globin1-ACACAACTGTGTTCAC-TAGC; globin2-CAACTTCATCCACGTTCACC. Reactions were carried out in 50-L volumes with 0.5 M primers and 2 mM MgCl 2. The reaction parameters were as follows: initial denaturation at 95°C for 5 min; 35 cycles each at 95°C for 1 min, 50°C for 1 min, and 72°C for 1 min; final extension at 72°C for 5 min.
DNA Sequencing
PCR products were cloned into vector pCR2.1 using the TA cloning kit (Invitrogen, Carlsbad, CA) and sequenced using the Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems Inc., Foster City, CA) and an automated fluorescent DNA sequencer (Model 373A; Applied Biosystems Inc.). DNA sequence analysis was facilitated by BLAST sequence similarity searches using the National Center for Biotechnology Information database (http://www.ncbi.nlm.nih.gov/BLAST/).
RESULTS
Autopsy Findings
Postmortem examination was limited to the lungs, larynx, trachea, thyroid, and a portion of vertebral bone. Examination of the larynx and trachea revealed numerous papillomas, ranging in diameter from less than 0.1 to 0.4 cm, extending from the larynx to the level of the carina. Several of the papillomas showed mild to moderate dysplasia (Fig. 1A, B) . The right and left mainstem bronchi did not contain papillomas. The lungs were firm and heavy (1450 g, combined weight). Both lungs were involved by numerous cavitary papillomas, ranging from 0.1 to 1.5 cm in diameter. The pulmonary papillomas consisted of squamous epithelium with underlying nests of squamous cells within alveolar spaces (Fig. 1C, D) . A rim of compressed uninvolved parenchyma in turn surrounded these areas. The squamous nests were distinguished from an invasive carcinoma by the presence of intact alveolar septa, low-grade cytology, a pushing border, and the absence of desmoplasia.
The pleura of the right lung was thickened by fibrosis, ranging from 0.2 to 0.5 cm in thickness. A 4.5-cm firm, partially necrotic, well-differentiated squamous cell carcinoma was present in the right upper lobe that encircled but did not invade the right mainstem bronchus (Fig. 2) . The carcinoma consisted of irregular, invasive tongues of keratinizing squamous cells with moderate to severe cytologic atypia. In contrast to the pulmonary squamous papillomas, the carcinoma was associated with a marked desmoplastic reaction and showed invasive destruction of surrounding alveolar parenchyma. Examination of hilar and peribronchial lymph nodes showed no evidence of metastatic disease. Foci of acute bronchopneumonia were also identified in sections of the right lung. The sections of thyroid and vertebral bone showed no evidence of metastatic carcinoma.
PCR-Based HPV Typing
To evaluate the association of the patient's carcinoma with HPV, DNA was extracted from sections of carcinoma, laryngeal papillomas, and, as a negative control, thyroid. A preparation of purified genomic HPV 16 DNA was used as a positive control. HPV DNA was detected in the patient's carcinoma and papillomas, as indicated by the presence of the expected 450 bp band, but HPV DNA was not detected in the preparation of thyroid DNA (Fig. 3) . The expected band was also amplified from the control preparation of purified HPV 16 DNA (data not shown). Sequence analysis of the amplified products demonstrated HPV serotype 11 in both the papillomas and carcinoma and confirmed that the control HPV DNA was serotype 16, as expected.
DISCUSSION
In this article, we describe a patient with RRP with pulmonary involvement who developed welldifferentiated squamous cell carcinoma of the lung approximately 17 years after the onset of papillomatosis. HPV 11 DNA was detected in both benign papillomas and squamous cell carcinoma. Numerous studies have examined the HPV serotypes associated with RRP and have identified HPV 6 and 11 as the causative agents both in cases limited to the larynx (9) and in cases with involvement of the lung (1, 10, 11 ). The frequency of individual HPV serotypes in juvenile-onset papillomas has been reported as 50 to 84% for HPV 6 and 25 to 37% for HPV 11 (12, 13) . However, a review of the literature reveals only four case reports of squamous cell carcinoma of the lung arising in the setting of pulmonary papillomatosis in which HPV typing was performed ( Table 1) . Comparison of the reported cases shows a common pattern of clinical features. As in our case, all of the patients described were men, with onset of RRP in early childhood (range, infancy to 5 years) and development of carcinoma in the third or fourth decade of life. Two of the patients had a history of tobacco use. None had been treated with irradiation before the diagnosis of carcinoma. HPV typing in each case showed HPV 11 DNA associated with the squamous cell carcinoma. The consistent finding of HPV 11 DNA is unlikely to represent simply the prevalence of this serotype in benign precursor lesions because HPV 6 has been detected in RRP even more frequently than HPV 11 (as discussed above).
Epidemiologic data have shown that HPV 11 is not among the specific HPV serotypes that are associated with malignant transformation, the socalled "high risk" or oncogenic HPV types (14) . Nonetheless, malignant transformation of lesions caused by HPV 11 does occur, although it is an infrequent occurrence (15, 16) . DNA sequence analysis has shown that specific viral mutations are associated with malignant transformation, demonstrating the role of specific viral genes in oncogenesis (17) . The increased frequency of detection of HPV 11 in tumors from immunocompromised patients indicates that host factors also influence the process of carcinogenesis (17) . In this context, the demonstration of mutations in host genes (specifically, allelic loss of the interferon-␤ gene and mutation of p53) associated with malignant transformation in a case of RRP (6) is provocative. However, the precise mechanism by which host mutations may contribute to malignant transformation in RRP is unknown, as is the role of viral mutations.
Genetic differences between HPV 11 and HPV 6 that could account for the skewing of the association between malignant transformation and HPV type in the setting of RRP are unknown. It is interesting that DiLorenzo et al. (5) reported a case of HPV type 6a-associated lung carcinoma arising in a patient with laryngeal papillomatosis. The authors did not comment, however, on prior irradiation therapy or the presence of pulmonary papillomas. It is therefore unclear whether their case represents malignant transformation of a pulmonary papilloma or an isolated lung lesion in a patient with disease limited to the larynx.
In contrast to juvenile-onset RRP, adult-onset papillomatosis shows a greater tendency to be solitary and is less likely to be associated with HPV 6 or 11 (18, 19) . It has also been reported in adult-onset papillomatosis that HPV is more frequently detected in laryngeal carcinomas than in dysplastic, noninvasive laryngeal papillomas, suggesting that HPV plays a later role in carcinogenesis in adultonset cases than in juvenile-onset cases (15) . HPV typing was performed in two cases of malignant transformation of adult-onset laryngeal papillomatosis. In these cases, squamous cell carcinomas of the larynx were found to be associated with HPV 6 (18) or HPV 18 (20) . Review of the literature shows no reported cases of malignant change of a pulmonary papilloma in the setting of adult-onset papillomatosis. Taken together, these differences in clinical presentation between juvenile-onset and adultonset RRP suggest that they may represent distinct clinical entities with differences in pathogenesis reflecting the association with different HPV serotypes.
In summary, we have demonstrated the association of HPV 11 with a squamous cell carcinoma of the lung arising in the setting of juvenile-onset RRP with pulmonary spread. Further studies on a larger series of patients are necessary to assess the relative risk of malignant transformation associated with various HPV types and to confirm that HPV 11 represents a "high risk" lesion in this clinical setting. Such information may prove to be of prognostic significance for patients with RRP.
